NYSE ARCA | ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 9.13% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.84% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.14% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.50% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.77% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.01% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 2.91% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.85% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.24% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.13% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.13% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.98% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.90% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.79% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.70% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.68% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.55% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.29% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.18% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.14% |